Avantor Inc., a leading global provider of mission-critical products and services to customers in the life sciences in its first-of-its-kind series of biopharma forums across India in Bengaluru, Hyderabad and Pune to highlighted importance of collaboration and technology advancements in India. It also addressed the challenges faced by the sector.
RADNOR, Pa., Sept. 21, 2023 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services for customers in the life sciences and technology industries, today announced the creation of a new Scientific Advisory Board (SAB), which will provide strategic guidance and consult on the Company's mid- to long-term research and development efforts to deliver solutions for the life sciences industry, including biotech and pharma customers.
Avantor, Inc., a global provider of mission-critical products and services to the life sciences, is relocating and significantly expanding the company's Bridgewater, NJ Innovation Center, which serves as a technology-driven research and collaboration environment where Avantor works with customers to develop and enhance their offerings. The new location will be double the current size of the available lab and pilot space.
Avantor Performance Materials, Inc., a global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, appointed R. Brent Jones executive vice president and chief financial officer, effective August 7, 2023. Jones will replace Thomas Szlosek, who will begin a new role outside the life sciences industry.
RADNOR, Pa., June 29, 2023 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, education and government, advanced technologies and applied materials industries, announced that it will release its second quarter 2023 financial results before the market opens on Friday, July 28, and will hold a conference call on the same day at 8:00 a.m. Eastern Time to discuss the results.
Avantor and Catalent have entered into a multi-year supply and services agreement. Avantor will be the primary supplier of a broad range of laboratory supplies, clinical and production materials, and services to Catalent, expanding the companies' existing relationship.
Avantor announced on Nov. 3, 2022 the opening of a new 69,000-ft2 distribution center in Dublin, Ireland. The facility is the most advanced distribution center in the company’s global network and enhances supply security due to its location to customers, according to a company press release.
Avantor, Inc., a global provider of products and services for the life sciences, has entered into an agreement with GeminiBio to deliver custom hydrated solutions and cell culture media to the biopharma industry.
Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced...
On May 10, 2022, Avantor announced that it had entered into an agreement with Cytovance Biologics, a contract development and manufacturing organization specializing in plasmid DNA, to manufacture research- and good manufacturing practice (GMP)-grade plasmids for viral vectors and messenger RNA (mRNA)-based vaccines and therapeutics.